TIMOPTIC-XE 0.50
Total Payments
$33,311
Transactions
1
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $33,311 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $33,311 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 2013-001 Opth Friedlander | Valeant Pharmaceuticals North America LLC | $33,311 | 1 |
Top Doctors Receiving Payments for TIMOPTIC-XE 0.50
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Dermatology | San Diego, CA | $33,311 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $33,311
- Total Doctors 1
- Transactions 1
About TIMOPTIC-XE 0.50
TIMOPTIC-XE 0.50 is a drug associated with $33,311 in payments to 1 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Valeant Pharmaceuticals North America LLC.
Payment data is available from 2017 to 2017. In 2017, $33,311 was paid across 1 transactions to 1 doctors.
The most common payment nature for TIMOPTIC-XE 0.50 is "Unspecified" ($33,311, 100.0% of total).
TIMOPTIC-XE 0.50 is associated with 1 research study, including "2013-001 Opth Friedlander" ($33,311).